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Abstract
Background Previous studies have shown thylakoids, the membrane proteins which are extracted from green leaves like spinach,
can induce satiety through homeostatic and non-homeostatic pathways. In this study, we reviewed the current human literature on
thylakoids’ characteristics and their relationship to satiety regulation and weight loss.
Methods A systematic search of literature published between January 1990 and May 2019 was conducted on the electronic
databases; including WEB OF SCIENCE, Cochrane Library, MEDLINE, Scopus, and EMBASE databases. We included all
clinical trials that addressed the effects of thylakoids or chloroplast intake on satiety and weight loss.
Results After excluding non-human studies, non-RCTs, duplications, studies with irrelevant data and interventions, eight studies
were included in the qualitative synthesis. All studies supported this hypothesis that thylakoids reduce the feeling of hunger by
increasing postprandial cholecystokinin and leptin and decreasing serum ghrelin, but the consequences of thylakoid intake on
anthropometric characteristics were controversial.
Conclusion In conclusion, our results may approve this postulation that receiving a thylakoid-enrichedmeal can decrease appetite
and probably food intake in short term; however, more studies are needed to explore the effects of long term supplementation
with thylakoids on weight loss in human subjects.
Keywords Appetite . Obesity . Satiety . Spinach . Thylakoid .Weight loss
Introduction
The World Health Organization (WHO) defines obesity as a
condition of excess body fat to the extent that health is im-
paired [1, 2]. Currently, obesity is highly prevalent in both
developed and developing countries. The number of over-
weight and obese individuals has increased at an alarming rate
recently as a result of which at least 2.8 million people die
each year (http://www.who.int/gho/ncd/risk_factors/obesity_
text/en/). In 2016, more than 1.9 billion adults (39% of
world population), 18 years and older, were overweight
among whom 650 million (13%) were obese [3].
Threatening trends in obesity prevalence during the last
decades could be explained by the negative influences of
industrialization on both diet and physical activity levels
[4, 5].
Obesity is a disorder of multifactorial pathogeneses [6].
Many psychological and physiological factors, such as taste
and composition of the meal, gastrointestinal motility, diges-
tion and absorption of nutrients, secretion of satiety hormones
and suppression of hunger hormones, can affect appetite [7].
Thylakoids are the internal photosynthetic membrane systems
of chloroplasts which can be extracted from green leaves like
spinach [8]. Thylakoids have a two-layer membrane which
separate their lumen from stroma of cytosol. The stacks of
10 to 20 thylakoids held together are called grana. The grana
are interconnected by stroma lamellae through junctions at the
margins of the granum [9]. Thylakoids consist of various
membrane-bound proteins, galactolipids, phospholipids, and
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s40200-019-00443-w) contains supplementary
material, which is available to authorized users.
* Farzad Shidfar
shidfar.f@iums.ac.ir
1 Student Research Committee, Department of Nutrition, School of
Public Health, Iran University of Medical Sciences, Tehran, Iran
2 Songhor Healthcare Center, Kermanshah University of Medical
Science, Kermanshah, Iran
3 Department of Nutrition, School of Public Health, Iran University of
Medical Sciences, Tehran, Iran
Journal of Diabetes & Metabolic Disorders
https://doi.org/10.1007/s40200-019-00443-w
antioxidants such as chlorophyll, carotenoids, zeaxanthin, and
lutein [8]. Hunger-suppressing and lipid- and glucose-
lowering properties of thylakoids have been shown in previ-
ous studies. The satiety-promoting effects of thylakoids, in
part, could be due to decreasing fat digestion through inhibi-
tion of pancreatic lipase/colipase activity which promotes the
release of hormones like cholecystokinin and glucagon-like
peptide-1(GLP-1) that signal satiety [10–13]. Administration
of thylakoids for 10 days modulated gut microbiota in the rat
[14]. Gut microbiota affects metabolism by fermenting carbo-
hydrates into short-chain fatty acids (SCFAs), such as acetate,
propionate, and butyrate. It has been found that SCFAs have
beneficial effects on satiety and insulin sensitivity since they
act as a ligand to free fatty acid receptors [15, 16].
Various animal and human studies have been conducted to
examine the effects of thylakoids on suppressing hunger and
weight loss. Erlanson-Albertsson et al. [17] also published a
review article about the same relationship, but they did not use
a systematic approach. Therefore, we decided to examine this
relationship more thoroughly using systematic criteria to draw
a more definitive conclusion.
Methods
Search strategy
A systematic search for articles published between January
1990 and May 2019 was conducted on the electronic data-
bases. WEB OF SCIENCE, Cochrane Library, MEDLINE,
Scopus and EMBASE databases were searched for related
studies by using the specified keywords (refer to search strat-
egy appendix). The bibliographies of the papers found in the
primary search were also investigated to recognize other pos-
sible related studies. The search was limited to human studies.
Selection criteria
We included articles in this review if they had the following
criteria: [1] were randomized double-blind, single-blind or not
blinded controlled trial (RCT) in their design, [2] were pub-
lished as original paper, [3] had a sample size of >5 subjects
per arm, [4] were performed on adult subjects aged >18 years
old, [5] used thylakoids or spinach extract alone (not in com-
bination) for intervention, [6] clinically investigated the ef-
fects of thylakoids or spinach extract in any dosages in human
subjects, [7] assessed any marker of weight loss and appetite
as the primary outcome variable, and [8] no other special
dietary regimen or supplementation were used in control or
intervention group. The final literature search yielded a total of
43 articles. After excluding non-human studies, non-RCTs,
duplications, studies with irrelevant data and studies with dif-
ferent interventions, eight studies were included in qualitative
synthesis (Fig. 1).We contacted the authors by email to ask for
further explanation if we found any ambiguity regarding the
papers meeting our inclusion criteria.
Quality assessment
The quality of the selected studies was assessed by means of a
five-point Jadad score conducted by two researchers separate-
ly. Jadad is a quality assessment tool in which critical evalua-
tion is made over three different domains: [1] randomization,
[2] blinding, and [3] an account of all patients. One point
would be assigned if the randomization and blinding were
mentioned in the paper and one extra point if their methods
were proper. Also one more point is assigned if the fate of all
patients were known. The minimum score for qualification of
the papers in this review was one point (one point for random-
ization) and the maximum score was five points.
Data extraction
Primary outcomes of interest in this systematic review were
weight and appetite. Two reviewers independently extracted
and cross-checked the following data from eligible papers:
name of the first author, publication date, the location of the
study, study design, participants’ characteristics, sample size,
composition and dosage of thylakoids, intervention duration,
variables measured, and the main outcomes of studies.
Articles were consulted again if there were any discrepancies
between the extracted data. In one study by Stenblom et al.
[12], same populations participating as the treatment group,
received three different thylakoids dosages as 3.7, 5 and 7.4 g/
day; therefore, we reported their results as three separate
pieces of evidence in this review.
Results
Eight studies met the criteria and were included in the quali-
tative synthesis. The quality of the selected studies in terms of
Jadad score is shown in Table 1.
The included studies are summarized in Table 2. Three
studies investigated variables related to appetites such as food
intake, hunger and desire for food and anthropometric features
in the long-term and five studies measured them in the post-
prandial state after thylakoids intake (acute studies). Due to
differences in study design and high heterogeneity, none of
these studies were eligible for meta-analysis.
Anthropometric characteristics
Only two studies measured the anthropometric features. In
one study thylakoids consumption (5 g/day) decreased body
weight as much as 1.5 kg on average more than the control
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group after 3 months [10]. Stenblom et al. reported only a
reduction in hip circumference, but no significant weight
change, after 8 weeks of supplementation with thylakoids
(5.6 g/day) [18]. Both studies were not able to show any sig-
nificant changes in on other anthropometric features like total
body fat, fat free mass (FFM) or waist circumference.
Appetite and food intake
Five studies investigated the effects of thylakoids on appetite
by the use of the Visual Analog Scales (VAS) questionnaire.
Among them, two studies showed a decreased urge for sweets
and chocolate and a reduction in hunger feeling after long-
term intervention [10, 18]. The duration and dosage of thy-
lakoids have been described in the previous section. Three
acute studies also support the hunger-suppressing and
satiety-promoting effects of thylakoids. Rebello et al.
showed that a single meal supplemented with 5 g of thy-
lakoids increases fullness and reduces hunger and pro-
spective intake over the 2-h period following consumption
[13]. Stenblom et al. examined two dosages of thylakoids
(3.7 g and 7.4 g) paired with a high carbohydrate break-
fast; VAS questionnaire was filled out every 15 min after
the start of the meal. Thylakoid intake was associated
with hunger suppression after 180 min compared to the
control group. There were no statistically significant dif-
ferences in the same parameters between the groups treat-
ed by the two dosages of thylakoids [19]. Stenblom et al.
conducted a more thorough investigation on the impact of
thylakoids on appetite in another trial with cross-over de-
sign. They found that supplementation with thylakoids
(5 g) in the morning reduces the feeling of hunger,
database searching 
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Fig. 1 PRISMA flow diagram
Table 1 Quality of the selected
studies in terms of JADAD score Study Randomization Blinding An account of all patients Total score
Stenbolm 2016 2 2 1 5
Montelius 2014 2 2 1 5
Kohnke 2009 0 2 1 3
Maruyama 2013 1 0 1 2
Rebello 2015 2 2 1 5
Stenblom 2013 1 2 1 4
Stenblom 2014 1 2 1 4
Stenblom 2015 2 2 1 5
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desiring palatable food, and carving sweet, salty and all
types of snacks and also increased the feeling of satiety
during the rest of the day [12].
Insulin, leptin, cholecystokinin, ghrelin and GLP-1
Elevated postprandial cholecystokinin (CCK) levels were re-
ported in two trials. No study investigated the long-term ef-
fects of thylakoids on CCK. Kohnke et al. used different dos-
ages of thylakoids (25 g, 50 g, and 25 g of delipidated thyla-
koid) in one meal. Serum CCK levels increased after all doses
of thylakoids compared to the control. Ghrelin was decreased
after consuming 25 g of thylakoid. Also, postprandial serum
leptin was increased after thylakoids consumption [20], but
long-term supplementation in overweight women had the op-
posite effect [18]. One study reported that long-term supple-
mentation with thylakoids elevates postprandial circulating
levels of GLP-1 [10]. Thylakoids intake in three studies had
no effects on serum insulin [10, 18, 21] and the results were
controversial in another two trials [19, 20].
Other effects
Serum glucose was increased in the thylakoids group in an
acute study [13], while consumption of thylakoids in long-
term lead to a lower glucose level in another trial [18]. No
significant changes were found in other studies. A minor pos-
itive effect on the amount and composition of the gut micro-
biota was reported after a 12-week intervention with five
grams of thylakoids [22].
Adverse effects
No significant adverse effects were reported in none of the
trials included in this article.
Discussion
We systematically reviewed the studies which examined the
effects of thylakoids on appetite. To the best of the authors’
knowledge, this is the first systematic review of clinical trials
on this topic. Hunger-suppressing effects of thylakoids were
reported in all studies that directly measured hunger and full-
ness (Table 2). This in part is due to inhibition of pancreatic
lipase/colipase activity and retardation of fat digestion as
shown in vitro studies [11, 23]; however, heat treatment could
reduce thylakoids’ efficiency in doing so [24]. Colipase
knockout mice had impaired weight gain compared to normal
mice [25], declaring that lipase/colipase inhibition can lead to
weight loss. Thylakoids like other biological membrane inhib-
it lipase/colipase complex by two types of mechanisms work-
ing together:
1- Thylakoids bind to the triacylglycerol/water interface; as
a result, it forms a sterical barrier impeding the lipase-
colipase complex from reaching its substrate. This mech-
anism is supported by electron microscopy.
2- Thylakoids bind to the lipase/colipase complex; thereby,
blocking its active site and preventing getting in touch
with the triglyceride substrate. This linkage involves both
ionic and hydrophobic interactions [11].
This suppression stimulates a compensatory release of en-
dogenous lipase/colipase and has been suggested as a mecha-
nism for increasing the enterostatin which is an appetite sup-
pressing pentapeptide [11, 26]. Gastrointestinal complications
such as steatorrhea are the common side-effects of lipase in-
hibitors. However, supplementationwith thylakoid for 10 days
didn’t change fecal fat in the rats treated with high-fat diet
[14]. In another study, no significant differences were seen
in fecal fat content of healthy human subjects after a three-
month supplementation with thylakoid [22]. These results
suggest that thylakoids may inhibit lipase activity in a revers-
ible manner that does not cause steatorrhea.
Animal studies showed that CCK serum elevates postpran-
dially after thylakoids intake [11, 27] and these results are
supported by two clinical trials included in this review
[19, 20]. Montelius et al. showed for the first time that GLP-
1 secretion increases after the consumption of a thylakoid-rich
breakfast in overweight women [10]. The most potent factors
in releasing GLP-1 are carbohydrate and fat. Retarded fat di-
gestion and CCK secretion that occur after thylakoids intake
are two probable mechanisms for the raise observed in serum
GLP-1 [28]. Delayed fat digestion leads to a reduced gastric
emptying and an increased secretion of CCK and GLP-1
[10, 19, 20, 22]. These two hormones themselves inhibit gut
motility [29, 30]. Also, serum levels of ghrelin, a potent
orexigenic hormone [31], were lowered after thylakoids intake
[20]. The reason whyMontelius et al. were not able to observe
any significant changes in serum ghrelin levels could be the
low dose of thylakoids they used (5 g), compared to 25 g of
thylakoid/day applied by Kohnke et al. Intestinal fat with the
mediation of CCK signaling could suppress ghrelin [32].
Leptin has a critical role in appetite and body weight [33].
Supplementation with thylakoids for 8 weeks caused a reduc-
tion in leptin serum in overweight women [18]. This is prob-
ably because of weight loss and reduction in body fat follow-
ing a thylakoid-rich diet. Clearly, the decline in leptin serum is
a natural consequence of weight loss [34]. This outcome was
different when studied in the short-term. Kohnke et al. report-
ed that postprandial leptin levels increased after receiving a
thylakoid-rich meal, describing another mechanism for
satiety-inducing features of thylakoid. This increase was not
observed after receiving delipidated thylakoids, suggesting
that these effects are only attributable to thylakoids with lipid
or lipid/protein properties, such as galactolipids, chlorophyll,
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carotenoids and, antioxidants like tocopherols [20]. Since no
more studies investigated the short-term effects of thylakoids
on serum leptin, the reason of this increase is still unclear.
The reduction in postprandial plasma insulin reported in
one trial [20] could be due to beneficial effects of thylakoids
on modifying the composition of intestinal microbiota which
may, in turn, decrease insulin and blood glucose concentra-
tions [14, 35]. Conversely, postprandial plasma insulin levels
were raised by thylakoids consumption in another clinical
trial; they hypothesized that CCK and GLP-1 could increase
insulin secretion and thylakoids may exert an incretin-like
effect [36]. Nonetheless, there were more RCTs investigating
plasma insulin after thylakoids intake, but they didn not report
any significant changes (Table 2). Overall, it is too soon to
draw a conclusion in this regard and this area warrants more
investigations.
Suppression of hedonic hunger which can be described as
an individual’s tendency to experience appetitive thoughts,
feelings, and urges about food in response to palatable food
[37], is another factor that induces satiety. Stenblom et al.
showed in three separate studies that receiving thylakoids de-
creases hunger and desire for salty, sweet and fatty snacks,
both after a single meal and a long-term supplementation
[12, 18, 19]. These results are also supported by other RCTs
[10, 13]. The synergistic effects of appetite-regulating hor-
mones, like CCK, GLP1, and ghrelin, contribute to the food
reward system [38–40] and could suppress hedonic hunger.
Moreover, the role of glucose and insulin homeostasis in con-
trolling reward system, particularly in urge for sweet, had been
determined [41], but studies examining effects of thylakoids
on serum insulin and glucose are still inconsistent to regard
that as a certain mechanism.
Animal studies demonstrate that rats and mice receiving
thylakoids had a significant weight loss or lower weight gain
compared to the control groups [11, 27, 42, 43], but only two
human studies measured this variable directly. Weight was
significantly decreased after 12 weeks of supplementation
with 5 g of thylakoids per day in one of these trials [10]. In
another study, although no significant difference in weight
loss was seen between the groups, based on appetite-
suppressing effects of thylakoids, it seems that weight loss
was achieved with less effort in the thylakoid-treated group
compared to the control [18].
Both population and diversion of gut microbiota can influ-
ence energy balance, weight loss, and glucose and lipid me-
tabolism [44–46]. Some Bifidobacterium and Lactobacillus
species showed anti-obesity effects in previous studies
[47–49]. Lactobacillus reuteri protected against the develop-
ment of diet-induced obesity in apo E-deficient mice [50].
This bacterium was increased in the distal ileum in rats receiv-
ing thylakoids compared to the control [14]. In the only hu-
man trial, the count of total and fragilis group bacteria was
increased in the feces of individuals after receiving thylakoids
for 3 months [22]. SCFAs are produced by microbiota in the
distal small intestine and colon from low-digestible carbohy-
drates. SCFAs receptors are located in colonic L cells causing
them to secret GLP-1 and PYY [51]. This suggests that gut






















Fig. 2 Probable mechanisms of
thylakoids on appetite
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hormones, such as GLP-1 and PYY. Additionally, SCFAs in-
duce fatty acid oxidation and inhibit de novo synthesis of
lipids leading to a reduction in plasma free fatty acids and
body weight [52]. Further studies are needed to investigate
the effects of thylakoids on population and diversion of gut
microbiota, especially those with anti-obesity features. The
probable mechanisms of thylakoids effects on appetite are
summarized in Fig. 2.
We were able to recognize the beneficial role of thylakoids
in controlling appetite and food intake, both in the short- and
the long-term, in the existing literature. But there is insuffi-
cient evidence to support the role of thylakoids in the preven-
tion or treatment of obesity and more human studies are need-
ed to ratify this possible capability. Systematic search and
assessing the quality of different trials were the strengths of
our study; however, scarcity of human studies and high het-
erogeneity of results rendered a meta-analysis impossible. Our
results are in line with the previous review by Erlanson-
Albertsson [17], with this difference that for the first time we
used systematic criteria for study inclusion.
Conclusion
In conclusion, our results show that, based on the existing
publications so far, receiving a thylakoid-enriched meal de-
creases appetite and probably food intake in the short term.
Both homeostatic and non-homeostatic factors are involved in
this reduction. But whether these appetite-lowering effects of
thylakoids could be a useful strategy in controlling obesity in
the long term is still ambiguous. More studies are needed to
investigate the effects of long-term supplementation with thy-
lakoids on weight loss in human subjects.
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